PARP inhibitors as first-line maintenance therapy in ovarian cancer: recommendations from an expert panel from Brazil by Aknar FC Calabrich, Daniele Xavier Assad, Graziela Dal-Molin, Andreia C Melo, Angelica Nogueira-Rodrigues, Karime Kalil, Andrea PG Guimarães, Michelle Samora Almeida, Carla Rameri de Azevedo, Daniela de Freitas, Alessandra Menezes Morelle, Ana Carolina Leite, Marcela Crosara, João Soares Nunes, Poliana Signorini, Eduardo Cronemberger, Rachel Cossetti, Rodrigo Guindalini, Eduardo Paulino, Fernando C Maluf

Get full text